Queensland Government to inject $1m into MRCF

The Queensland Government will kick another $1m into the Medical Research Commercialisation Fund (MRCF), a VC fund jointly supported by the federal, Qld, Vic, NSW and WA... [+]

> Posted in Biotechnology on 17 April, 2014

BioProspect to acquire mental illness test

BioProspect (ASX:BPO) will acquire a stake in Invatec and a global licence to a potential heart rate-based diagnostics test for a wide range of mental health disorders. [+]

> Posted in Health & medical on 14 April, 2014

Reforming Employee Share Schemes for the good of start-up innovation

An effective employee share scheme would enable start-up companies to attract and retain the quality employees they need to become established successful... [+]

> Posted in Biotechnology on 14 April, 2014

Burnet research and development agreement with China

The Burnet Institute has signed a $5 million agreement with China to support the development of low-cost diagnostic tests. [+]

> Posted in Health & medical on 14 April, 2014

The many faces of viral research

It is sometimes said that the best ideas are those already thought of, and that is exactly what structural biologist Dr Fasséli Coulibaly in Melbourne is banking on... [+]

> Posted in Life sciences on 14 April, 2014

Latest News

Drawbridge anaesthetic beats propofol during trial

Drawbridge Pharmaceuticals announced that anaesthesia candidate Phaxan outperformed the SOC... [+]

> Posted in Biotechnology

TGA's low value turnover exemption scheme under review

The Therapeutic Goods Administration (TGA) has announced a review of the low value turnover... [+]

> Posted in Biotechnology

Chemical cues direct sperm in healthier choice

Cues given off by unfertilised female mussel eggs act as a genetically compatible chemoattractant... [+]

> Posted in Life sciences

The evolution of chloroquine

A different way of administering chloroquine could see its renewed use to treat malaria. [+]

> Posted in Health & medical

Nexvet raises $33.6m in financing round

Nexvet Biopharma will put the proceeds of a $33.6m Series B financing round to funding key... [+]

> Posted in Biotechnology

Click here for your FREE subscription

Australian Life Scientist: The Magazine

The magazine for research professionals in the life science and biotech sector across Australia. Click for your FREE subscription